Lord, Abbett & Co »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Lord, Abbett & Co

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Lord, Abbett & Co from 13F filings

Historical chart of Lord, Abbett & Co investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Lord, Abbett & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Lord, Abbett & Co

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.9M 3.7M 1.33
2025-03-31 $7.8M 6.1M 1.28

More positions owned by Lord, Abbett & Co

NVIDIA Corporation (NVDA)
Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Morgan Stanley (MS)
Wells Fargo & Company (WFC)
Apple (AAPL)
Crh (CRH)
Parker-Hannifin Corporation (PH)
Taiwan Semiconductor Mfg (TSM)
Facebook Inc cl a (META)
Wal-Mart Stores (WMT)
Charles Schwab Corporation (SCHW)

View all positions for Lord, Abbett & Co

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
Point72 Asset Management
LMR Partners
Balyasny Asset Management
Alberta Investment Management Corporation
Jain Global
Jpmorgan Chase & Co
Lazard Asset Management
Lombard Odier Asset Management
Absolute Investment Advisers
Citadel Advisors
Linden Advisors
Calamos Advisors
Tenor Capital Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1